Sheikh Bilal Ahmad, Aarif Ali, Midhat Bilal, Shahzada Mudasir Rashid, Amir Bashir Wani, Rahil Razak Bhat & Muneeb U. Rehman. (2023) Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders. Cellular and Molecular Neurobiology 43:6, pages 2437-2458.
Crossref
Charalampos Skarlis & Maria Anagnostouli. (2019) The role of melatonin in Multiple Sclerosis. Neurological Sciences 41:4, pages 769-781.
Crossref
M. Gunata, H. Parlakpinar & H.A. Acet. (2020) Melatonin: A review of its potential functions and effects on neurological diseases. Revue Neurologique 176:3, pages 148-165.
Crossref
Abdulla Watad, Kassem Sharif, Nicola Luigi Bragazzi, Benjamin Lichtbroun, Howard Amital & Yehuda Shoenfeld. 2019. Mosaic of Autoimmunity. Mosaic of Autoimmunity
229
234
.
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin & Jean-Noël Vallée. (2018) Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches. International Journal of Molecular Sciences 19:4, pages 1212.
Crossref
Sifat Maria, Rebekah M. Samsonraj, Fahima Munmun, Jessica Glas, Maria Silvestros, Mary P. Kotlarczyk, Ryan Rylands, Amel Dudakovic, Andre J. van Wijnen, Larry T. Enderby, Holly Lassila, Bala Dodda, Vicki L. Davis, Judy Balk, Matt Burow, Bruce A. Bunnell & Paula A. Witt-Enderby. (2018) Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis. Journal of Pineal Research 64:3, pages e12465.
Crossref
Abdulla Watad, Shir Azrielant, Nicola Luigi Bragazzi, Kassem Sharif, Paula David, Itay Katz, Gali Aljadeff, Mariana Quaresma, Galya Tanay, Mohammad Adawi, Howard Amital & Yehuda Shoenfeld. (2017) Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity. Journal of Autoimmunity 82, pages 13-30.
Crossref
Daniela Giuliani, Alessandra Ottani, Laura Neri, Davide Zaffe, Paolo Grieco, Jerzy Jochem, Gian Maria Cavallini, Anna Catania & Salvatore Guarini. (2017) Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives. Progress in Neurobiology 148, pages 40-56.
Crossref
Abdulla Watad, Shir Azrielant, Alessandra Soriano, Danielle Bracco, Arsalan Abu Much & Howard Amital. (2016) Association between seasonal factors and multiple sclerosis. European Journal of Epidemiology 31:11, pages 1081-1089.
Crossref
Mauricio F. Farez, Ismael L. Calandri, Jorge Correale & Francisco J. Quintana. (2016) Anti-inflammatory effects of melatonin in multiple sclerosis. BioEssays 38:10, pages 1016-1026.
Crossref
S. Gustavsen, H.B. Søndergaard, D.B. Oturai, B. Laursen, J.H. Laursen, M. Magyari, H. Ullum, M.H. Larsen, F. Sellebjerg & A.B. Oturai. (2016) Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population. Multiple Sclerosis and Related Disorders 9, pages 104-109.
Crossref
J.R. Calvo & M.D. Maldonado. (2016) The role of melatonin in autoimmune and atopic diseases. AIMS Molecular Science 3:2, pages 158-186.
Crossref
Patricia J. Lardone, Nuria Álvarez-Sánchez, Ana Rodríguez-Rodríguez, Juan M. Guerrero & Antonio Carrillo-Vico. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice
117
141
.
Daniel Golan, Elsebeth Staun-Ram, Lea Glass-Marmor, Idit Lavi, Orit Rozenberg, Sara Dishon, Mira Barak, Sophia Ish-Shalom & Ariel Miller. (2013) The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis. Brain, Behavior, and Immunity 32, pages 180-185.
Crossref
Antonio Carrillo-Vico, Patricia Lardone, Nuria Álvarez-Sánchez, Ana Rodríguez-Rodríguez & Juan Guerrero. (2013) Melatonin: Buffering the Immune System. International Journal of Molecular Sciences 14:4, pages 8638-8683.
Crossref
Lena Melamud, Daniel Golan, Rafael Luboshitzky, Idit Lavi & Ariel Miller. (2012) Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis. Journal of the Neurological Sciences 314:1-2, pages 37-40.
Crossref
Robert Paur & M. Schmidbauer. (2009) Die Neuro-Endokrino-Immunologie der Multiplen Sklerose. Psychopraxis 12:4, pages 18-28.
Crossref
Robert Pichler, Konstantin Sfetsos, Birgit Badics, Sabrina Gutenbrunner & Josef Auböck. (2006) Vitiligo patients present lower plasma levels of α-melanotropin immunoreactivities. Neuropeptides 40:3, pages 177-183.
Crossref
Emily Reinke & Zsuzsa Fabry. (2006) Breaking or making immunological privilege in the central nervous system: The regulation of immunity by neuropeptides. Immunology Letters 104:1-2, pages 102-109.
Crossref
A.P Friedman. (2004) Do hyporesponsive genetic variants of the melanocortin 1 receptor contribute to the etiology of multiple sclerosis?. Medical Hypotheses 62:1, pages 49-52.
Crossref
Walter H. Chang, Kyle T. Chang & Jimmy Li. 2003. Biological Effects of Electromagnetic Fields. Biological Effects of Electromagnetic Fields
624
732
.
Franz Halberg, Germaine Cornélissen, Ario Conti, Georges J. M. Maestroni, Cristina Maggioni, Federico Perfetto, Roberto Salti, Roberto Tarquini, George S. Katinas & Othild Schwartzkopff. 2001. The Pineal Gland and Cancer. The Pineal Gland and Cancer
66
116
.
R.C. Olson. (1998) A proposed role for nerve growth factor in the etiology of multiple sclerosis. Medical Hypotheses 51:6, pages 493-498.
Crossref
Reuven Sandyk. (1997) I. Role of the Pineal Gland in Multiple Sclerosis: A Hypothesis. The Journal of Alternative and Complementary Medicine 3:3, pages 267-290.
Crossref
P.A. Corley. (1996) Acquired immune deficiency syndrome: The glucocorticoid solution. Medical Hypotheses 47:1, pages 49-54.
Crossref
Brandon Chandos, Arifulla Khan, Henry Lai & James C. Lin. 1996. Biological Effects of Magnetic and Electromagnetic Fields. Biological Effects of Magnetic and Electromagnetic Fields
161
169
.